πŸ‡ΊπŸ‡Έ FDA
Patent

US 7271150

Modified growth hormone

granted A61KA61K38/00A61P

Quick answer

US patent 7271150 (Modified growth hormone) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P43/00, A61P5/06